MedTrace Logo

Trial of Ropinirole in Motor Recovery After Stroke

NCT00221390 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2016-11-01

No results posted yet for this study

Summary

The purpose of this study is to assess efficacy, as well as safety, of Ropinirole in improving movement among patients with chronic stroke.

Conditions

  • Cerebrovascular Accident
  • Hemiparesis

Interventions

DRUG

Ropinirole (+ physical therapy)

DRUG

(vs.) Placebo + physical therapy

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Steven C Cramer, MD · University of California, Irvine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2007-02-28
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00221390 on ClinicalTrials.gov